Skip to content

Immediate Versus Postponed Freeze-all Embryo Transfer in Hyperresponders

Immediate Versus Postponed Freeze-all Embryo Transfer in Hyperresponders, a Multicenter Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05483270
Enrollment
845
Registered
2022-08-02
Start date
2022-08-30
Completion date
2024-11-24
Last updated
2024-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IVF

Brief summary

This is a multicenter, randomised controlled trial. The investigators plan to randomise 836 participants to the immediate FET or the postponed FET from the day of oocyte retrieval to the last day of that menstrual cycle in a 1:1 rate. Primary outcome will be the live birth rate after the embryo transfer.

Detailed description

It is postulated that postponing embryo transfer for at least one menstrual cycle after a freeze-all cycle can minimise the possible residual negative effect caused by ovarian stimulation and can promote the resumption of a normal ovulatory cycle and the receptivity of endometrium. Nevertheless, emerging evidence suggests a higher live birth rate in the immediate freeze-all embryo transfer (FET) cycles compared to that in the delayed group. It is unclear the whether postponed FET is superior in hyperresponders. The investigators hypothesize the success rate in the postponed FET for at least one menstrual cycle after oocyte retrieval is higher than in the immediate FET in hyperresponders. Objective: To evaluate whether the postponed FET for at least one menstrual cycle after oocyte retrieval is superior to the immediate FET in the first menstrual cycle after oocyte retrieval in hyperresponders in terms of live birth rates. Design: a multicenter, randomised controlled trial Patients: The investigators plan to randomise participants to the immediate FET and the postponed FET from the day of oocyte retrieval to the last day of that menstrual cycle. Primary outcome: live birth rate after the embryo transfer. Patients who get pregnant will be followed up until 6 weeks after delivery. Sample size: The investigators plan to enroll 836 participants in a 1:1 rate.

Interventions

BIOLOGICALthe timing of embryo transfer in freeze-all cycles

Immediate FET group Freeze-all embryo transfer will be carried out in the menstrual cycle immediately following oocyte retrieval. Postponed FET group Freeze-all embryo transfer will be carried out during the second menstrual cycle to 6 months after oocyte retrieval.

Sponsors

Women's Hospital School Of Medicine Zhejiang University
CollaboratorOTHER
The Affiliated Hospital Of Guizhou Medical University
CollaboratorOTHER
Shengjing Hospital
CollaboratorOTHER
Peking University Third Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 42 Years
Healthy volunteers
Yes

Inclusion criteria

* Women aged 20 to 42 years old; * Written informed consent; * Women scheduled for freeze-all embryo transfer; * Women with the number of oocyte collected higher than 15.

Exclusion criteria

* Women with a history of at lease three failed transfer cycles; * Women with an endometrial thickness less than 7 mm on the triggering day; * Severe uterine malformations.

Design outcomes

Primary

MeasureTime frameDescription
Live birth after the first embryo transferAt least 22 months gestation after the first embryo transfer cycleLive birth is defined as the delivery of at least one baby after 22 weeks of gestation that exhibits any sign of life.

Secondary

MeasureTime frameDescription
Ongoing pregnancy12 weeks' gestation or beyond after the first embryo transfer cycledefined as pregnancy with detectable heart rate at 12 weeks' gestation or beyond
Biochemical pregnancyabout 12 days after embryo transferdefined as a positive pregnancy test
Ectopic pregnancyabout 6 weeks after embryo transferdefined as embryo implanted at any site other than the endometrial lining of the uterus cavity
Miscarriage6-22 weeks of gestationdefined as spontaneous loss of a clinical pregnancy before 22 completed weeks of gestational age, in which the embryo(s) or fetus(es) is/are nonviable or is/are absorbed or expelled from the uterus.
Cumulative live birth6 month after the first embryo transferthe cumulative rate of live born children conceived within six months of the first FET cycle.
Pre-eclampsiaafter 20 weeks of gestationdefined as the development of gestational hypertension with proteinuria (≥300 mg/24-hour urine collection or 30 mg/dL in single urine sample) of new onset after 20 weeks of gestation
Gestational hypertensionafter 20 weeks of gestationdefined as the development of blood pressure greater than 140/90 mmHg after pregnancy without proteinuria or other signs of preeclampsia
Clinical pregnancyaround 7 weeks' gestation after the first embryo transfer cycledefined as at least one gestational sac on ultrasound at around 7 weeks' gestation with the detection of heart-beat activity
Premature rupture of membrane (PROM) ratethe day of deliverydefined as rupture of the amniotic membranes before the onset of labor including PROM at term and preterm PROM
Preterm deliveryless than 37 and more than 21 weeks' gestational agedefined as delivery of a fetus at less than 37 weeks' gestational age
Placenta previathe day of deliverydefined as a placenta that is implanted over or very close to the internal cervical orifice
Postpartum hemorrhagethe day of deliverydefined as the loss of 500 ml of blood or more after completion of the third stage of labor
Birth weightthe day of deliveryBirth weight
Stillbirththe day of deliverydefined as the absence of signs of life at or after birth
Mode of deliverythe day of deliveryVaginal birth or Caesarean Section
Gestational diabetes mellitusafter 24 weeks of gestationdefined as carbohydrate intolerance of variable severity with onset or first recognition during pregnancy as determined from the diagnosis in the obstetrical medical record

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026